Identification of IL-17-producing FOXP3+ regulatory T cells in humans
Charlotte, NC Finished my titration on compounded tirzepatide, transitioned to a maintenance dose
More than 40% of those began in 2022 or earlier, signaling more long-term issues and not just temporary setbacks
They affect GH release by acting at hypothalamic, pituitary, and peripheral levels
That gap is the largest asymmetry between patent position and product position in the entire field, and it is the cleanest signal in the data that either Sanofi is preparing an undisclosed program or intends to collect royalties from everyone else
These compendia use various criteria for the conditions under which a non-FDA approved indication would be included, including a judgment by editorial staff regarding the quality and quantity of evidence, and the magnitude of benefit versus harms